Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5797603 | The Veterinary Journal | 2015 | 6 Pages |
â¢Feline herpesvirus type 1 (FHV-1) infection is important in shelter-housed cats.â¢A randomized, masked, placebo-controlled study was performed.â¢The study examined the efficacy of a single oral dose of 125 or 500âmg of famciclovir on FHV-1 shedding and clinical signs.â¢Approximately 40% were already shedding virus at the time therapy was instituted.â¢Famciclovir administered at shelter intake was not efficacious.
Although famciclovir is efficacious in feline herpesvirus type 1 (FHV-1)-infected cats, effects of a single dose early in disease course have not been reported. In this two part, randomized, masked, placebo controlled study, cats received a single dose of 125âmg famciclovir (nâ=â43) or placebo (nâ=â43; pilot study), or 500âmg famciclovir (nâ=â41) or placebo (nâ=â40; clinical trial) on entering a shelter. FHV-1 PCR testing was performed, bodyweight and food intake were recorded, and signs of respiratory disease were scored prior to and 7 days following treatment. FHV-1 DNA was detected in 40% of cats in both parts at study entry. In the pilot study, ocular and nasal discharge scores increased from days 1 to 7 in famciclovir and placebo treated cats. Sneezing scores increased and bodyweight decreased in famciclovir-treated cats. The proportion of cats in which FHV-1 DNA was detected increased over time in all cats in the pilot study. In the clinical trial, food intake and median clinical disease scores for nasal discharge and sneezing increased from days 1 to 7 in both groups and demeanor scores worsened in famciclovir-treated cats. The proportion of cats shedding FHV-1 DNA was greater on day 7 than on day 1 in cats receiving 500âmg famciclovir. A single dose of famciclovir (125 or 500âmg) administered at shelter intake was not efficacious in a feline population in which 40% were already shedding FHV-1.